Stock Under $10 with 50-100% upside potential - 14 Days FREE!

TiVo: Small-Cap Winner

Stock quotes in this article: TIVO, DRL, OXGN, PRAN, JAG, AEZS, ACAD 

NEW YORK (TheStreet) -- Shares of TiVo (TIVO) jumped 38% to $11.54 Wednesday, with volumes topping 30 million shares in noon trading.

The U.S. Court of Appeals upheld a district court's ruling of contempt against EchoStar Communications in an ongoing patent dispute between the two companies. TiVo is seeking a permanent injunction against EchoStar and Dish Network for infringing on a TiVo patent.

Puerto Rico-based bank Doral (DRL) saw its shares soar 32% to $1.37 after it reported a net profit of $3.3 million, reversing a $3.5 million loss in the year ago quarter on the back of improving asset quality.

Shares of Prana Biotech (PRAN) were gaining 16% to $2.58 after the company said it was accelerating the development of its PBT2 compound that is used to treat Alzheimer's Disease and Huntington's Disease.

Shares of bio-pharma company Oxigene (OXGN) were gaining 7% to $1.73. The company announced that clinical investigators have enrolled the first patient in phase 2 trials of of Zyberstat in patients with ovarian cancer.

AEZS Pharmaceuticals (AEZS) and ACADIA Pharmaceuticals (ACAD) were other biotech stocks in play on Tuesday, rising 5% and 4.6% respectively.

Shares of Jaguar Mining (JAG) surged 5.6% to $5.77 after JPMorgan upgraded its rating on the gold miner to an overweight from neutral.

--Written by Shanthi Bharatwaj in New York



>To contact the writer of this article, click here: Shanthi Bharatwaj.

>To follow the writer on Twitter, go to http://twitter.com/shavenk.

>To submit a news tip, send an email to: tips@thestreet.com.

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,294.50 -12.67 -0.08%
NASDAQ 3,459.42 -3.88 -0.11%
S&P 500 1,650.51 -4.84 -0.29%
US 10 Yr 2.023% -0.003

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs